We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
-$1.12B
Cap. Flow %
-1.77%
Top 10 Hldgs %
32.11%
Holding
999
New
156
Increased
303
Reduced
370
Closed
127

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.35B
2
INSM icon
Insmed
INSM
+$197M
3
HUBB icon
Hubbell
HUBB
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
SLNO
Soleno Therapeutics
SLNO
+$161M

Sector Composition

Rank Sector Weight
1 Technology 30.31%
2 Healthcare 13.97%
3 Financials 11.89%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRL icon
701
Hormel Foods
HRL
$13.8B
$6.56M 0.01%
265,346
-1,600
-0.6% -$44.3K
TE
702
T1 Energy
TE
$1.55B
$6.54M 0.01%
3,000,000
+2,200,000
+275% +$3.51M
BRKR icon
703
Bruker
BRKR
$7.8B
$6.5M 0.01%
200,000
-98,366
-33% -$3.51M
EL icon
704
Estee Lauder
EL
$30.9B
$6.45M 0.01%
73,184
-141,300
-66% -$12.6M
MGM icon
705
MGM Resorts International
MGM
$11.4B
$6.44M 0.01%
185,800
-3,600
-2% -$132K
SLV icon
706
iShares Silver Trust
SLV
$29.8B
$6.36M 0.01%
150,000
-50,000
-25% -$1.8M
KGC icon
707
Kinross Gold
KGC
$30.4B
$6.21M 0.01%
+250,000
New +$4.81M
ATRC icon
708
AtriCure
ATRC
$2.01B
$6.17M 0.01%
175,000
-100,000
-36% -$3.45M
LRMR icon
709
Larimar Therapeutics
LRMR
$436M
$6.14M 0.01%
+1,900,000
New +$7.12M
SYBT icon
710
Stock Yards Bancorp
SYBT
$2.61B
$6.12M 0.01%
87,500
-50,800
-37% -$3.92M
BDX icon
711
Becton Dickinson
BDX
$48.8B
$6.12M 0.01%
32,695
-129,251
-80% -$24M
ATXS
712
DELISTED
Astria Therapeutics
ATXS
$6.07M 0.01%
834,000
-41,000
-5% -$277K
JBHT icon
713
JB Hunt Transport Services
JBHT
$25.1B
$5.98M 0.01%
44,600
-27,200
-38% -$3.91M
SIRI icon
714
SiriusXM
SIRI
$10.1B
$5.97M 0.01%
256,402
-275,000
-52% -$6.36M
CAMP icon
715
CAMP4 Therapeutics
CAMP
$282M
$5.88M 0.01%
+1,960,784
New +$3.63M
MOH icon
716
Molina Healthcare
MOH
$10B
$5.8M 0.01%
30,300
-44,628
-60% -$8.21M
RHP icon
717
Ryman Hospitality Properties
RHP
$7.84B
$5.73M 0.01%
63,940
+53,940
+539% +$5.27M
RYAN icon
718
Ryan Specialty Holdings
RYAN
$5.76B
$5.64M 0.01%
+100,000
New +$5.92M
CLDT
719
Chatham Lodging
CLDT
$607M
$5.6M 0.01%
835,181
+85,181
+11% +$610K
LYV icon
720
Live Nation Entertainment
LYV
$42.3B
$5.57M 0.01%
34,100
+5,200
+18% +$822K
BEN icon
721
Franklin Resources
BEN
$17.3B
$5.56M 0.01%
+240,510
New +$5.94M
IMVT icon
722
Immunovant
IMVT
$8.2B
$5.54M 0.01%
343,600
-120,000
-26% -$1.94M
GL icon
723
Globe Life
GL
$14.4B
$5.53M 0.01%
38,700
-36,900
-49% -$5M
LADR
724
Ladder Capital
LADR
$1.21B
$5.41M 0.01%
496,002
-88,998
-15% -$1M
ORIC icon
725
Oric Pharmaceuticals
ORIC
$1.34B
$5.37M 0.01%
447,366
+81,966
+22% +$862K

Similar funds

Adage Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adage Capital Partners held 999 positions worth $63.1B, up 6.4% from $59.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q3 2025 filing shows 156 new, 303 increased, 370 reduced and 127 closed positions. Its largest new stake was Chevron: 3,284,841 shares worth $510M. The largest sale was Hess, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2025 buy was Chevron: 3,284,841 shares worth $510M.
  • Adage Capital Partners added most to Royalty Pharma in Q3 2025, an estimated $216M increase.
  • Adage Capital Partners's biggest Q3 2025 reduction was Insmed, cutting an estimated $197M.
  • Adage Capital Partners fully exited Hess in Q3 2025, selling an estimated $1.35B.
  • Adage Capital Partners's ten largest holdings make up 32% of its $63.1B portfolio in Q3 2025.
  • Adage Capital Partners opened 156 new positions and closed 127 in Q3 2025.
  • Adage Capital Partners's portfolio value rose 6.4% quarter-over-quarter to $63.1B.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.